Authors


Konghwa Chiu

Latest:

Spectrophotometric Determination of Lead

The authors developed a reliable spectrophotometric method for determining and measuring trace amounts of lead in various samples.


Adam C. Fisher, PhD

Latest:

Artificial Intelligence in Pharmaceutical Manufacturing

FDA is anticipating how AI may advance manufacturing and improve supply chain security.


Gaurav Tolia

Latest:

The Role of Dendrimers in Topical Drug Delivery

This review provides an update of how dendrimer technology is being applied to the development of novel systems for various topical delivery applications.


Rajeev Singh Raghuvanshi, PhD

Latest:

Assessment of Nanosuspension Formulation for Intranasal Administration

Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.



Prometheus Group

Latest:

Pharmaceutical Companies Can Optimize Enterprise Asset Management and Achieve Success

An integrated platform that keeps real-time data in a single location can be a major asset for pharmaceutical companies, as it saves time and money, leading to better quality products and higher profits.


BIOGRUND

Latest:

Easy Coloring for Liquid- and Solid-Dosage Drug Forms

***Live: Tuesday, November 24, 2020 at 9am EST| 2pm GMT| 3pm CET*** Coloring as an aesthetic value for a product is becoming more important for pharmaceutical and nutritional products and helps differentiate between various grades of active ingredients. This webcast introduces the world of easy coloring, answers questions about pigments, pigment blends, and how to color solid- or liquid-dosage forms in an efficient way. Register for this webcast to learn how ready-to-use coloring systems can simplify production process.*** On demand available after final airing until Nov. 24, 2021.***


Scott Deakins

Latest:

Serialization: Reducing Counterfeit Drugs and Increasing Sales

An effective data structure and simple communication between production, logistics, and sales are essential for delivering this level of accountability, traceability, and security.


Greg Paddon-Jones

Latest:

Emerging Applications of Vitamin E TPGS in Drug Delivery

The author discusses some new applications of TPGS in the pharmaceutical field that should see this versatile excipient retain its place in the drug formulators toolbox.


Cameron Graham

Latest:

High-Growth Microbial Fermentation for the Manufacture of Biologics

Challenges in fermentation can be addressed through equipment changes, facility design, and process development.


Rasmus Kidmose

Latest:

Accelerating Project Delivery with a Lean Alternative to DBB

Lean delivery offers a promising solution to supply and manufacturing bottlenecks by integrating project teams early on and widening the team’s field of view.


Bioduro

Latest:

BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation

How BioDuro is expanding its global CRDMO footprint by improving integrated capabilities and delivering high-quality, end-to-end solutions for drug development and manufacturing


Maria DiPietro

Latest:

Elaboration, Expansion, and Evolution in Outsourcing of Clinical Research

The rising complexity of clinical research protocols has necessarily expanded the CRO landscape.


Chris Stumpf

Latest:

Untethered Data: Unifying and Contextualizing Drug Discovery Data

Capturing and curating R&D data are crucial to realizing the full value of advanced analytics.



Nusrat Motlekar

Latest:

Designing and Delivering Therapeutic Proteins

An updated book summarizes recent research for formulators and drug-delivery specialists.


H. Gregg Claycamp

Latest:

Elicitation of Expert Knowledge and Probabilities for Controlling Subjectivity in Risk-Based Decision Making

More attention should be given to how expert opinions and judgments are elicited for reducing uncertainty in quality risk management and risk-based decision making.


Kevin E. Noonan

Latest:

Protecting Intellectual Property for COVID-19 Innovations

Opposition to IP protection for COVID-19 vaccines, therapies, tests and other technologies may only prevent eradication and treatment of the disease.


Fouad Benamira

Latest:

A Harmonized Approach to Performing a Risk-Based Audit Trail Review

The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.


Aizon

Latest:

The Relevance and Readiness of AI for GMP Manufacturing: An Industry Perspective

Leverage artificial intelligence (AI) for a more streamlined GMP manufacturing process.



RaviKanth Valigari

Latest:

Beyond GenAI: The Training-Free Discovery Potential of LLMs in a Drug Safety and Regulatory Context

Life sciences data sets can be vast and complex to process, but up to now bringing intelligent automation systems up to speed and validating them has felt debilitatingly onerous. Large language models tackle these barriers head on. Ramesh Ramani and RaviKanth Valigari, technology innovators at ArisGlobal, explain.


Ilina Markova

Latest:

EGA Position On The EC's Proposal For A Falisifed Medicines Directive

Although the European Generic medicines Association (EGA) n has welcomed the European Commission's proposal for a Directive on the falsification of medicines, it has also identified subjects that are of specific relevance to the European generic medicines industry.


Telstar

Latest:

New alloys for manufacturing freeze-dryers

This article explores the challenges found in manufacturing of a pressure vessel as main component for freeze drying technology


Margaret (Peggy) Marino

Latest:

Considerations for Monoclonal Antibody Bioprocess and Manufacturing Validation

Regulatory, analytical, and process concerns must be taken into account.


Chris Halling

Latest:

Improving Packaging Security

Legislation has prompted the pharma industry to seek technologies that can be used to secure a product throughout the supply chain.


Kerri Robles

Latest:

Collaborative Efforts Address Key Data Integrity Challenges

Maintaining a quality culture across the diverse functions in a bio/pharmaceutical company is difficult. Representatives of the Quality Coordinating Committee of IQ Consortium report on collaborative efforts to address data integrity and the modernization of FDA’s good laboratory practice regulations.


Dean Bornilla

Latest:

Major Growth & Investment at Pace® Life Sciences

Dean Bornilla, Pace® Life Sciences, highlights his organization's future role in supporting biopharmaceutical development and manufacturing coast-to-coast.


Prasanth Sambaraju

Latest:

Pooling of Batches for Stability Data Analysis

One of the main purposes of stability testing is to establish shelf life for these drug products. The goal of this paper is to create an Excel spreadsheet, which can be used for statistical testing of more than three stability batches for poolability.


Allen Welsher

Latest:

Viewpoint: Data Integrity and Its Ties with Personal Integrity

The root cause of the most serious integrity issues has generally been a lapse of ethical behavior on the part of an individual.